Tag: Food and Drug Administration
Peanut allergy therapy receives $12M boost from Breakthrough Victoria
The Victorian Government announced a $12 million investment in Aravax, a local biotechnology firm, in a push to revolutionise peanut allergy treatment.
4DMedical gets US FDA green light clearance for CT-based ventilation product
Respiratory imaging technology company 4DMedical Limited announced the receipt of clearance from the US Food and Drug Administration (FDA) for its CT-based ventilation product CT LVAS.
Featured Article
Unlock global potential with Bank of Sydney’s trade finance solutions
In an increasingly globalised economy, Australian manufacturers face the dual challenge of managing complex international supply chains while seizing opportunities for global expansion. Trade finance, a crucial financial tool, can help businesses mitigate risks, improve cash flow, and facilitate cross-border trade with confidence.
